Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21064135rdf:typepubmed:Citationlld:pubmed
pubmed-article:21064135lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C0935850lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C0521116lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C0022771lld:lifeskim
pubmed-article:21064135lifeskim:mentionsumls-concept:C1514923lld:lifeskim
pubmed-article:21064135pubmed:issue1lld:pubmed
pubmed-article:21064135pubmed:dateCreated2010-12-24lld:pubmed
pubmed-article:21064135pubmed:abstractTextWe report the outcome of 236 pediatric umbilical cord blood transplantations (UCBT) performed in Korea. Given that the sources of the grafts were mostly unrelated donors (n = 226; 95.8%), only the results of unrelated UCBT were included for all statistics. The most frequent primary disease was acute leukemia (n = 167). In total, 91.7% of recipients were seropositive for cytomegalovirus (CMV). The median doses of nucleated cells and CD34+ cells were 4.84 × 10(7)/kg and 2.00 × 10(5)/kg, respectively. The median times to neutrophil (>0.5 × 10(9)/L) and platelet recovery (>20 × 10(9)/L) were 18 and 45 days, respectively. Grade 2-4 acute graft-versus-host-disease (GVHD) and chronic GVHD developed in 41.1 and 36.1% of cases, respectively. Forty-five patients developed CMV disease. The 5-year overall and event-free survival were 47.5 and 36.9%, respectively. Multivariate analysis revealed that adverse factors for survival of the whole cohort were total body irradiation-based conditioning (P = 0.007), salvage transplant (P = 0.001), failure to achieve early complete chimerism (P < 0.0005), and CMV disease (P = 0.001). The outcomes of the single- and double-unit UCBT (n = 64) were similar, while double-unit recipients were heavier (P < 0.0005) and older (P < 0.0005). We conclude that double-unit UCBT is a reasonable option for older or heavier children and that the thorough surveillance of CMV infection and the development of an effective CMV therapeutic strategy may be especially important for Korean children, whose CMV seroprevalence exceeds 90%.lld:pubmed
pubmed-article:21064135pubmed:languageenglld:pubmed
pubmed-article:21064135pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21064135pubmed:citationSubsetIMlld:pubmed
pubmed-article:21064135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21064135pubmed:statusMEDLINElld:pubmed
pubmed-article:21064135pubmed:monthJanlld:pubmed
pubmed-article:21064135pubmed:issn1096-8652lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:LeeYoung HoYHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:KimSun...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:HwangTai JuTJlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:KookHoonHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:LeeSoo HyunSHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:SungKi...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:YooKeon HeeKHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:KooHong HoeHHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ParkSang...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:AhnHyo SeopHSlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:KimHack KiHKlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ParkHyeon...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ChoBinBlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:RyuKyung HaKHlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ShinHee...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:SeoJong JinJJlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:YooEun SunESlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:HahJeong OkJOlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:KangHyoung...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:LimYoung...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ImHo JoonHJlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ChungNak...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ParkJun EunJElld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:BaekHee JoHJlld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:JungHyun...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ParkSeong...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:HanDong...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:LimYeon...lld:pubmed
pubmed-article:21064135pubmed:authorpubmed-author:ParkByung...lld:pubmed
pubmed-article:21064135pubmed:copyrightInfo© 2010 Wiley-Liss, Inc.lld:pubmed
pubmed-article:21064135pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21064135pubmed:volume86lld:pubmed
pubmed-article:21064135pubmed:ownerNLMlld:pubmed
pubmed-article:21064135pubmed:authorsCompleteYlld:pubmed
pubmed-article:21064135pubmed:pagination12-7lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:meshHeadingpubmed-meshheading:21064135...lld:pubmed
pubmed-article:21064135pubmed:year2011lld:pubmed
pubmed-article:21064135pubmed:articleTitleCurrent status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases.lld:pubmed
pubmed-article:21064135pubmed:affiliationDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.lld:pubmed
pubmed-article:21064135pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21064135pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21064135pubmed:publicationTypeMulticenter Studylld:pubmed